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C oronary heart disease arising from atherosclerosis is closely associated with hypertension and is a leading cause of cardiogenic death worldwide. 1 Atherosclerosis is associated with increased mitochondrial reactive oxygen species (ROS) production, mitochondrial DNA damage accumulation, and progressive respiratory chain dysfunction. 2 Endothelium damage induced by mitochondrial dysfunction contributes to coronary atherosclerosis. [3] [4] [5] However, the application of ROS scavengers, including different antioxidants, has not been successful in ameliorating coronary heart disease in clinical trials. 6 These antioxidant strategies generally reduce the total levels of tissue and cellular ROS, which participate in both physiological and pathological signalings.
Mitochondria are the primary source of ROS and are associated with multiple ROS-related signaling pathways. 7 Alterations in mitochondrial mass and activity contribute to metabolic syndrome, 7 and defective oxidative phosphorylation by the mitochondrial respiratory chain disturbs ROS generation. 8 Altering the mitochondrial membrane potential (MMP) may activate ROS production by modulating the activity of complexes I (CI) and III (CIII). 9 Therefore, in addition to their role as the cellular powerhouse, mitochondria represent promising therapeutic targets for atherosclerosis. 10 On the basis of emerging research, rather than directly eliminating all ROS, pharmacological interventions targeting specific factors in mitochondria or selectively inhibiting pathological ROS signaling cascades have been suggested to alleviate mitochondrial dysfunction and Abstract-Coronary heart disease arising from atherosclerosis is a leading cause of cardiogenic death worldwide.
Mitochondria are the principal source of reactive oxygen species (ROS), and defective oxidative phosphorylation by the mitochondrial respiratory chain contributes to ROS generation. Uncoupling protein 2 (UCP2), an adaptive antioxidant defense factor, protects against mitochondrial ROS-induced endothelial dysfunction in atherosclerosis. The activation of transient receptor potential vanilloid 1 (TRPV1) attenuates vascular dysfunction. Therefore, whether TRPV1 activation antagonizes coronary lesions by alleviating endothelial mitochondrial dysfunction and enhancing the activity of the protein kinase A/UCP2 pathway warrants examination. ApoE /UCP2 −/− mice were fed standard chow, a high-fat diet (HFD), or the HFD plus 0.01% capsaicin. HFD intake profoundly impaired coronary vasodilatation and myocardial perfusion and shortened the survival duration of ApoE −/− mice. TRPV1 or UCP2 deficiency exacerbated HFD-induced coronary dysfunction and was associated with increased ROS generation and reduced nitric oxide production in the endothelium. The activation of TRPV1 by capsaicin upregulated UCP2 expression via protein kinase A phosphorylation, thereby alleviating endothelial mitochondrial dysfunction and inhibiting mitochondrial ROS generation. In vivo, dietary capsaicin supplementation enhanced coronary relaxation and prolonged the survival duration of HFD-fed ApoE −/− mice. These effects were not observed in ApoE −/− mice lacking the TRPV1 or UCP2 gene. The upregulation of protein kinase A /UCP2 via TRPV1 activation ameliorates coronary dysfunction and prolongs the lifespan of atherosclerotic mice by ameliorating endothelial mitochondrial dysfunction. Dietary capsaicin supplementation may represent a promising intervention for the primary prevention of coronary heart disease. (Hypertension. 2016;67:451-February 2016 reduce the production of cell-damaging ROS. 11 Protein kinase A (PKA) has been implicated in the pathogenesis of atherosclerosis. PKA activation attenuates Gi protein expression and vascular proliferation in genetically hypertensive rats by inhibiting ROS and ROS-mediated signaling pathways. 12 The PKA catalytic subunit alters the cardiac mitochondrial redox state and the MMP via mitochondrial ROS generation. 13 Uncoupling protein 2 (UCP2), an anion transporter embedded in the inner mitochondrial membrane, acts as an adaptive antioxidant defense factor to protect against endothelial dysfunction in cardiovascular diseases.
14 UCP2 mediates a low degree of mitochondrial uncoupling that primarily maintains the MMP below a certain threshold that is adequate to drive ATP synthesis but is sufficiently low to limit ROS formation.
15
UCP2 overexpression inhibits endothelial ROS generation, inflammatory activation. 16 Increased UCP2 expression may be related to a decreased incidence of coronary artery disease in humans, 17 whereas UCP2 deficiency leads to reduced antioxidant capacity and cardiovascular diseases.
18 UCP2 can be activated by stimulating the cAMP-PKA pathway. 19 However, it remains unknown whether interventions involving these ROSrelated signaling pathways protect against coronary lesions.
Currently, the primary therapeutic approaches applied to treat overt coronary heart disease include drug therapy and invasive coronary interventions. In addition, lifestyle modifications such as dietary changes are gaining increasing attention for the prevention of cardiovascular diseases. In recent years, we showed that a dietary factor, capsaicin, the pungent ingredient in chili peppers, activates the cation channel transient receptor potential vanilloid 1 (TRPV1) and prevents endothelial oxidative stress via the upregulation of UCP2 in diabetic mice. 20 TRPV1 activation reduces lipid accumulation in vascular smooth muscle cells and subsequently prevents aortic atherosclerosis in ApoE knockout (ApoE −/− ) mice. 21 Furthermore, TRPV1 activation also lowers high blood pressure by promoting endothelial PKA/endothelial nitric oxide synthase (eNOS) phosphorylation in genetically hypertensive rats. 22 However, it remains to be determined whether targeting ROS-related signaling pathways antagonizes coronary dysfunction and its related cardiac lesions. In this study, we aimed to investigate whether the dietary factor capsaicin ameliorates mitochondrial ROS-induced coronary lesions by modulating the TRPV1/ PKA/UCP2 signaling pathways in atherosclerotic mice.
Materials and Methods
Materials and methods are available in the online-only Data Supplement.
Results

TRPV1 and UCP2 Deficiency Exacerbated Coronary Artery Dysfunction
Previous studies showed that consuming an high-fat diet (HFD) impairs endothelial function in humans and rodents. 23, 24 To test whether TRPV1 and UCP2 might protect against coronary endothelial dysfunction in atherosclerosis, male ApoE (Tables S1-S3  in the online-only Data Supplement) . Acetylcholine-induced endothelium-dependent relaxation was impaired in coronary artery rings from mice fed on HFD (Figure 1A-1C ; Figure S1 ). The administration of the NOS inhibitor, NG-nitro-l-arginine methyl ester, abolished these differences (Figure 1A-1C ; Figure  S1 ). When compared with mice fed on normal diet, nitroglycerin-induced endothelium-independent relaxation was impaired in the mice fed on HFD (Figure 1D-1F ; Figure S2 ). There was no difference of endothelium-dependent or endothelium-independent relaxation among the ApoE −/− mice fed on normal diet or HFD ( Figure S3 ). These results suggest that HFD consumption impairs coronary relaxation in TRPV1-or UCP2-deficient ApoE −/− mice.
TRPV1 and UCP2 Deficiency Reduced Coronary Blood Flow and Myocardial Perfusion
Myocardial ischemia occurs when the atheromatous process limits blood flow through the coronary arteries. Progressive luminal narrowing by plaque is the principal cause of myocardial infarction. 25 To examine whether coronary lesions induced by HFD affect the cardiac status, coronary flow velocity was assessed via ultrasonography ( Figure 2A ). The results showed that coronary flow velocity was increased because of coronary stenosis in HFD-fed mice ( Figure 2B ). Electrocardiographic examination showed significantly more extensive ischemic ST-segment depression in HFD-fed mice ( Figures 2C and 2D Figure 3A and 3B). HFD intake decreased the NO level in the aorta of the HFD-fed mice ( Figure 3C Figure 3C and 3D). These data indicate that TRPV1 or UCP2 deficiency promotes ROS generation and reduces NO production in the endothelium, especially in HFD-fed mice.
TRPV1 Deficiency-Induced and UCP2 DeficiencyInduced ROS Generation Were Linked to Endothelial Mitochondrial Dysfunction
We sought to determine whether TRPV1 or UCP2 deficiencyinduced excess ROS generation is associated with endothelial mitochondrial dysfunction. Oxidized low-density lipoprotein (ox-LDL), a potent proatherogenic factor, increased cytosolic ROS and mitochondrial ROS generation in cultured endothelial cells (ECs) (Figure 4A and 4B). We further examined whether TRPV1 or UCP2 affects mitochondrial function in cultured ECs treated with ox-LDL. Mitochondrial respiratory function was measured via high-resolution respirometry ( Figure 4C ). The ox-LDLtreated ECs displayed a general reduction in mitochondrial respiration, which was associated with impaired mitochondrial CI and CII function ( Figure S5 ). Specifically, all of the mitochondrial functional parameters, including routine respiration, leak respiration of CI, CI and CI plus CII oxidative phosphorylation capacity, and electron transfer system capacity were markedly impaired in ox-LDL-treated ECs ( Figure 4D ). Capsaicin, a TRPV1 agonist, ameliorated ox-LDL-induced mitochondrial dysfunction, but this effect of capsaicin was suppressed by the UCP2 inhibitor genipin ( Figure 4D ). The MMP was mildly decreased in ox-LDL-treated ECs. TRPV1 activation by capsaicin significantly reduced endothelial MMP ( Figure 4E ). In contrast, the inhibition of UCP2 increased endothelial MMP ( Figure 4E ). CI is an important source of mitochondrial ROS. 26 We further determined the protein abundances of CI, as represented by subunit 9. It showed that TRPV1 activation by capsaicin increased NADH dehydrogenase [ubiquinone] 1 α subcomplex subunit 9 expression in ox-LDL-treated ECs, but this effect of capsaicin was blocked by the inhibition of UCP2 ( Figure 4F ). These results indicate that TRPV1 activation ameliorates endothelial mitochondrial dysfunction induced by ox-LDL in a UCP2-dependent manner.
TRPV1 Activation Suppressed Endothelial ROS Generation by Activating PKA and UCP2
The mechanism by which TRPV1 modulates UCP2 remains unclear. We reported that TRPV1 activation upregulated UCP2 expression via PKA phosphorylation in the vasculature of diabetic mice. 20 Here, we further studied the effect of dietary capsaicin supplementation on phosphorylated PKA (p-PKA) and UCP2 expression in aortae from mice of different genotypes receiving either the HFD or the HFD plus capsaicin. Both p-PKA/PKA and UCP2 expressions were increased in the aorta from capsaicin-treated ApoE −/− mice, but this effect of capsaicin treatment was not detected in the aorta from ApoE Figure 5A and 5D). These results were further validated in vitro. TRPV1 activation by capsaicin increased p-PKA expression in cultured ECs, but this increase was inhibited by a TRPV1 or PKA antagonist ( Figure 5E ). Furthermore, the administration of capsaicin dose-dependently increased UCP2 expression in ECs in the presence of ox-LDL ( Figure S6 ). However, this effect was inhibited by blockade of TRPV1, PKA, or UCP2 ( Figure 5F ). To assess whether TRPV1 activation by capsaicin reduced endothelial ROS generation via the TRPV1/PKA/UCP2 pathway, we inhibited TRPV1, PKA, or UCP2 using their respective antagonists. Both cytosolic ROS and mitochondrial ROS generation induced by ox-LDL were inhibited by capsaicin treatment ( Figure 5G and 5H). In contrast, the inhibition of TRPV1, PKA, or UCP2 abolished the suppression of endothelial ROS generation mediated by capsaicin ( Figure 5G and 5H). Thus, these results suggest that TRPV1 activation antagonizes ROS generation and increases NO production via the upregulation of the p-PKA and UCP2 pathways.
TRPV1 Activation Attenuated Coronary Lesions and Improved the Prognosis of Atherosclerotic Mice
In HFD-fed ApoE −/− mice, long-term (24 weeks) capsaicin consumption significantly attenuated coronary lesions, including amelioration of myocardial perfusion, reduction of ROS generation and elevation of NO level in the endothelium, restoration of coronary artery endothelium-dependent relaxation, and alleviation of myocardial ischemia (Figure 6A-6G; Figure  S7 ). However, these beneficial effects of capsaicin were not detected in ApoE Figure 6H and 6I). These data show that chronic dietary capsaicin supplementation attenuates coronary lesions and improves prognosis in a TRPV1-/UCP2-dependent manner.
Discussion
The findings of the present study demonstrate a critical role of TRPV1/UCP2/PKA in the protection against coronary endothelial dysfunction via the preservation of endothelial mitochondrial function. We showed that HFD intake profoundly impaired coronary vasodilatation and myocardial perfusion in ApoE −/− mice. Furthermore, TRPV1 or UCP2 deficiency exacerbated these coronary lesions by disrupting mitochondrial respiratory chain function, promoting mitochondrial ROS generation, and reducing NO bioavailability. The functional dietary factor capsaicin attenuated these coronary endothelial lesions and markedly prolonged survival via TRPV1 activation-mediated regulation of UCP2/PKA and via inhibition of mitochondrial ROS signaling in HFD-fed ApoE −/− mice. However, these beneficial effects were not observed in TRPV1-or UCP2-deficient ApoE −/− mice. This evidence suggests that interventions involving mitochondrial-related signaling cascades could be promising therapeutic targets.
Impairment of Protective Targets Increases Mitochondrial ROS Generation in Coronary Endothelial Dysfunction
Coronary atherosclerosis is the underlying substrate of acute coronary syndrome. Coronary endothelial dysfunction contributes to the occurrence of acute coronary syndrome. 25 Endothelial function in both the aorta and the mesenteric arteries was impaired in obese diabetic mice on HFD. 24 Moreover, coronary endothelial function is disrupted in type 2 diabetic patients and rodents. 27, 28 The vascular redox status greatly contributes to endothelial homeostasis by modulating the function of TRP channels. 29 Mitochondrial ROS play an important role in the progression of coronary atherosclerosis and subsequent myocardial ischemic injury. 29 TRP channels, such as the TRPV or TRPC family members, were found to be redox sensitive and be able to functionally interact with ROS. 30 In this study, we showed that HFD consumption significantly impaired coronary endothelial function and limited myocardial perfusion in ApoE −/− mice. TRPV1 or UCP2 deficiency exacerbated HFD intake-induced coronary lesions. Furthermore, these coronary lesions were closely associated with excess mitochondrial ROS generation and reduced NO bioavailability.
Certain protective targets antagonize coronary atherosclerosis and subsequent myocardial ischemic injury induced by excess mitochondrial ROS generation.
11 UCP2 has been shown to act as an adaptive antioxidant defense factor by protecting endothelial function in atherosclerosis. UCP2 can be activated by ROS or ROS by-products, thus UCP2 limits mitochondrial ROS generation via a negative feedback mechanism. 31 Mitochondrial ROS generation highly depends on the MMP. 15 Cheurfa et al 17 reported that increased UCP2 expression is associated with a reduced incidence of coronary artery disease in male patients with type 2 diabetes mellitus. Other studies have found that UCP2 overexpression actually reduces endothelial ROS generation, inflammatory activation, and apoptosis. 16, 32 The present study showed that ox-LDL, a key factor that initiates endothelial damage, reduced the MMP but slightly increased UCP2 expression. Minor increases in the UCP2 levels were not sufficient to suppress ROS generation in ECs. These results suggest that impairment of protective factors such as UCP2 and eNOS promotes cellular and mitochondrial ROS generation and exacerbates coronary lesions in ApoE −/− mice receiving HFD.
Mitochondrial Dysfunction Is Responsible for Excess ROS Generation
We further determined how mitochondrial respiratory chain dysfunction is linked to excess endothelial ROS generation in ECs. ox-LDL can cause direct oxidative damage to mitochondrial respiratory complexes. 4 Moreover, ox-LDLinduced ROS generation was dependent on the activation of NADPH (nicotinamide adenine dinucleotide phosphate) oxidase. 33 This source of ROS could damage mitochondrial respiratory complexes and subsequently trigger mitochondrial ROS generation. In the present study, we showed that ox-LDL increased both cellular and mitochondrial ROS generation in vitro and significantly reduced the capacity of mitochondrial oxidative phosphorylation and electron transfer system in cultured ECs. Previous studies showed that PKs play an important role in mitochondrial ROS generation. PKCε phosphorylates members of the mitochondrial respiratory chain, in particular, CI, CII, and CIII, which have been previously implicated in ROS generation.
11 PKA-dependent phosphorylation enhances the activity of CI and reduces mitochondrial ROS generation. 34 We showed that p-PKA expression was reduced in ox-LDL-treated ECs, and that this effect was accompanied by decreased CI activity and protein expression; however, ROS generation was enhanced in cultured ECs treated with ox-LDL. These results indicate that the mechanism by which ox-LDL enhances endothelial ROS generation involves the disruption of mitochondrial respiratory function and the PKA pathway. Santulli et al 35 and Xie et al 36 reported that in addition to mitochondrial dysfunction, excess ROS production 
TRPV1 Activation Antagonizes ROS-Mediated Coronary Lesions by Ameliorating Mitochondrial Dysfunction and Enhancing the UCP2/PKA Pathway
Strategies to ameliorate ROS-induced coronary lesions have received extensive attention in recent years. Although different ROS scavengers have generally been used to treat cardiovascular diseases in clinical trials, the strategy of eliminating total tissue or cellular ROS has not been successful for acute coronary syndrome treatment. 6 Thus, mitochondria-based therapeutics that modulate ROS signaling represent a new approach to coronary atherosclerosis management. In recent years, lifestyle modifications, such as dietary interventions, have become an attractive strategy in the prevention of atherosclerosis. TRPV1, which modulates intracellular Ca 2+ homeostasis and PK activity, plays an important role in vascular physiology and pathophysiology. 37 Capsaicin, a pungent compound found in hot chili peppers, is a specific TRPV1 antagonist. Transdermal administration of capsaicin improves the ischemic threshold in patients with stable coronary disease. 38 Our previous studies showed that TRPV1 activation by dietary capsaicin alleviates metabolic disorders and attenuates aortic atherosclerosis as well as hypertension. 21, 33, 39, 40 In this study, we further demonstrated that chronic dietary capsaicin supplementation ameliorated HFDinduced endothelial dysfunction in the coronary arteries and prolonged the lifespan of ApoE −/− receiving HFD. Moreover, we showed that the activation of TRPV1 by dietary capsaicin increased UCP2 expression and reduced ROS generation in ECs and arteries, and that these effects were associated with −/− mice fed with HFD or HC. **P<0.01 vs HFD; ##P<0.01 vs the HC-fed ApoE −/− group. n=15. All data are expressed as mean±SEM. Data were assessed using 2-tailed Student t tests. Concentrationresponse curves were analyzed via nonlinear regression followed by Student t tests for comparisons between 2 groups. Survival curves were calculated by the Kaplan-Meier method and compared using the log-rank test. UCP2 indicates uncoupling protein 2.
by guest on November 11, 2017 http://hyper.ahajournals.org/ Downloaded from increased protein expression of CI in a PKA-dependent manner. These results suggest that TRPV1 activation ameliorates mitochondrial dysfunction and increases the p-PKA and UCP2 levels resulting in reduced endothelial ROS generation and improved cardiac prognosis in ApoE −/− mice on HFD. Ca 2+ plays an important role in mitochondrial function. 41 In addition, PKA has been shown to play a crucial role in RyR2 (type 2 ryanodine receptor) phosphorylation and mitochondrial Ca 2+ overload, which affect mitochondrial function and cardiac performance. 42 This study showed that capsaicin-mediated PKA phosphorylation in endothelium might affect the mitochondrial Ca 2+ level in ECs. Moreover, Ca 2+ plays a critical role in blood pressure regulation via a mechanism that involves eNOS activation through phosphorylation events. 43 Calcium signaling defects produce a hypertensive phenotype and reduced cardiac angiogenesis after myocardial damage. 43 Whether TRPV1 activation by capsaicin also affects cardiac angiogenesis in ApoE −/− mice receiving the HFD plus capsaicin warrants investigation.
TRPV1 activation by capsaicin in vascular smooth muscle cells reduced vascular lipid accumulation and attenuated atherosclerosis. 21 Moreover, vascular smooth muscle cell mitochondria contribute to oxidative stress and vascular dysfunction. 44, 45 Whether TRPV1 activation by capsaicin attenuates mitochondrial dysfunction in vascular smooth muscle cells remains uncertain. HFD consumption impaired nitroglycerin-induced endothelium-independent relaxation of the coronary artery. However, dietary capsaicin improved endothelium-dependent relaxations, but not endothelium-independent relaxation of the coronary artery from ApoE −/− mice receiving HFD plus capsaicin. Nitroglycerine-mediated cGMP-dependent activation of PKI is the major pathway that regulates vascular tone. 46 However, it is unclear whether capsaicin-mediated TRPV1 activation is associated with cGMP-dependent PKI activity. This could be one reason for the different response to nitroglycerine.
In summary, HFD consumption remarkably impaired coronary artery function in atherosclerotic rodents. TRPV1 or UCP2 deficiency exacerbated the coronary lesions caused by HFD consumption via mitochondrial dysfunction-mediated ROS generation. Our mechanistic evidence indicates that TRPV1 activation by capsaicin increased PKA/UCP2 expression in ECs, which suppressed mitochondrial dysfunction and ultimately attenuated the HFD-induced coronary lesions and prolonged the survival of ApoE −/− mice. Taken together, the findings of this study suggest that dietary capsaicin supplementation may represent a promising lifestyle modification for the primary prevention of coronary heart disease.
Perspectives
This study demonstrated that TRPV1 activation by capsaicin ameliorated endothelial mitochondrial lesions by increasing PKA/UCP2 expression, and that dietary capsaicin ultimately antagonized HFD-induced coronary dysfunction and prolonged the survival of ApoE −/− mice. Taken together, dietary capsaicinmediated TRPV1 activation may represent a promising lifestyle intervention for the primary prevention of coronary heart disease.
What Is New?
• Capsaicin-induced transient receptor potential vanilloid 1 activation antagonizes endothelial mitochondrial lesions and ameliorates coronary dysfunction via transient receptor potential vanilloid 1-mediated upregulation of the protein kinase A/uncoupling protein 2 pathway.
• Chronic dietary capsaicin prolongs the survival of ApoE −/− mice fed on high-fat diet.
What Is Relevant?
• Modulating endothelial mitochondrial function by activating transient receptor potential vanilloid 1 could serve as a novel strategy for the primary prevention of coronary heart disease.
Summary
Transient receptor potential vanilloid 1 activation via dietary capsaicin antagonizes coronary dysfunction and prolongs the lifespan of atherosclerotic mice on high-fat diet. The mechanism underlying this effect of capsaicin is associated with the elevation of the eNOS/ NO levels and the inhibition of mitochondrial reactive oxygen species generation via the improvement of mitochondrial respiratory chain function and protein kinase A/uncoupling protein 2 signaling in endothelial cells. Dietary capsaicin may represent a promising lifestyle modification for the primary prevention of coronary heart disease.
Detailed Methods
Mouse strain, diet, and treatment TRPV1 knockout (TRPV1 -/-) mice and ApoE -/-mice of the C57BL/6J background were purchased from Jackson Laboratory (Bar Harbor, ME, USA). UCP2 knockout (UCP2 -/-) mice of the C57BL/6J background were kind gifts from Chengyu Zhang (Model Animal Research Center, Nanjing University, Nanjing, China). ApoE -/-/TRPV1 -/-and ApoE -/-/UCP2 -/-mice were generated by breeding ApoE -/-mice with TRPV1 -/-or UCP2 -/-mice respectively. The resulting heterozygous progeny were interbred with each other to produce homozygotic ApoE -/-/TRPV1 -/-and ApoE -/-/UCP2 -/-mice. These mice were backcrossed for a minimum of 7 generations. The mice were housed at 23-24℃ under a 12-hour light/dark cycle. At the age of 6 weeks, ApoE -/-, ApoE -/-/TRPV1 -/-and ApoE -/-/UCP2 -/-male mice were randomized into three groups (n=25, 10 for general experiment and 15 for survival duration recording) and were fed standard chow (ND, 10% kcal% fat, 70% kcal% carbohydrate, 20% kcal% protein), a high fat diet (HFD, 45% kcal% fat, 35% kcal% carbohydrate, 20% kcal% protein), or a high fat diet plus 0.01% capsaicin (HC) for 24 weeks. At the end of experiment, the mice were sacrificed. Blood was collected from the carotid arteries, and plasma was separated immediately. Tissues were stored in liquid nitrogen for Western blot analysis. All of the experiments were approved by the Experimental Animal Ethics Committee and conducted according to the institutional animal care guidelines (Daping Hospital, Third Military Medical University).
Echocardiography
Transthoracic echocardiography was performed using a high-frequency Vevo770 ultrasound system (VisualSonics Inc, Toronto, ON, Canada) equipped with a 30-MHz central frequency scan head. The mice were anesthetized via isoflurane (4%) inhalation, and anesthesia was maintained via mask ventilation (isoflurane 1.8%). The mice were positioned on a temperature-controlled heating pad to maintain normothermia (37±1°C) to optimize physiological conditions and to reduce hemodynamic variability. Fur was removed from the chest to gain a clear image. Using a left parasternal long-axis view, the B-mode left coronary artery was imaged with the Doppler sample volume placed in the proximal left coronary artery as described previously with some modifications. 1 The left coronary artery flow spectrum was recorded as the peak diastolic velocity of the left coronary artery. All measurements were analyzed by an experienced investigator.
Electrocardiography (ECG)
ECG was performed under isoflurane (1.5%) anesthesia. The mice were placed on a temperature-controlled heating pad (37°C) for 10 minutes to acclimate before ECG measurement. The 60-min ECG recordings were obtained simultaneously using an ML780 Power Lab System (AD Instruments, Castle Hill, NSW, Australia). Then, the recordings were analyzed offline.
2
Vasoreactivity measurement using wire myographs 3 After the mice were sacrificed, the coronary arteries were dissected in oxygenated ice-cold Krebs solution containing (mM) 119 NaCl, 2.5 CaCl 2 , 4.7 KCl, 1.2 MgSO 4 , 1.2 KH 2 PO 4 , 25 NaHCO 3 , and 11.1 D-glucose. Changes in the isometric tone of the coronary artery rings were recorded using a four-chamber wire myograph (model 610M; Danish Myo Technology, Aarhus, Denmark) as previously described with some modifications. 3 Briefly, the arterial segments were stretched to an optimal baseline tension and then allowed to equilibrate for one hour. Vasorelaxation was assessed in vessels preconstricted with 5-HT (10 μM) in response to acetylcholine (from 10 -9 M to 10 -5 M), or nitroglycerine (from 10 -9 M to 10 -5 M). In some cases, the arterial rings were incubated with the eNOS inhibitor NG-nitro-L-arginine methyl ester (L-NAME; 100 μM, 30 minutes) before 5-HT-stimulated precontraction. Endothelium-independent relaxation in response to nitroglycerine (from 10 -9 M to 10 -5 M) was also measured. All concentrations are reported as the final molarity in the organ bath.
Cell culture and treatment protocol
Primary cultured human umbilical vein endothelial cells (HUVECs) were purchased from Beijing Beina Chuanglian Biotechnology Institute (Beijing, China) and were incubated at 37℃/5% CO 2 in M199 (Gibco, Gaithersburg, MD, USA) supplemented with 15% fetal bovine serum, heparin, bovine endothelial cell growth factor, 50 μg/mL penicillin and 100 μg/mL streptomycin (Gibco, Gaithersburg, MD, USA). HUVECs were incubated for 12 h in ox-LDL (100 μg/mL, Yiyuan Biotechnologies, Guangzhou, China) alone or together with capsaicin (1 μM), the TRPV1 antagonist 5'-iodo-resiniferatoxin (iRTX, 1 μM), the PKA inhibitor KT5720 (2 μM) and the UCP2 inhibitor genipin (10 μM) as previously reported.
4
Evaluation of ROS generation and NO levels in the endothelium of the mouse aorta After dissection, aortic segments were incubated in DHE (Sigma-Aldrich, St Louis, MO, USA) for 30 min or in DAF-2 DA (Sigma-Aldrich, St Louis, MO, USA) for 45 min at 37℃ in Krebs solution followed by washing and slicing open. To quantify DHE and DAF-2 DA fluorescence, the endothelium specimens were placed between two coverslips on an inverted fluorescence microscope (Nikon TE2000; Nikon Corporation, Tokyo, Japan) as described previously. 4 Images were acquired, and the fluorescence intensity was analyzed using NIS-Elements 3.0 software (Nikon).
Measurement of ROS generation in HUVECs
ROS were detected using the DHE fluorescent probe for cytosolic ROS detection or MitoSOX Red (Invitrogen, Barcelona, Spain) for mitochondrial ROS detection. After 12 hours of treatment, the cells were washed and incubated at 37℃in the dark with 10 μM DHE for 30 minutes or 5 μM MitoSOX Red for 10 minutes. Then, the fluorescence intensity was measured using a fluorescent plate reader (Fluoroskan Ascent Fluorometer; Thermo Helsinki, Finland). The ROS concentration is expressed as the normalized value relative to the fluorescence intensity in the control cells.
High-resolution respirometry of mitochondrial function
After the indicated treatments, HUVECs were harvested via trypsin digestion and centrifuged at 800 rpm for 3 min at room temperature. Then, the pellet was resuspended in mitochondrial respiration medium for high-resolution respirometry. 5 Mitochondrial respiratory function was determined in a two-channel titration injection respirometer (Oxygraph-2k; Oroboros Instruments, Innsbruck, Austria). The cell suspension was transferred separately to oxygraph chambers at a final density of approximately 1×10 6 cells/mL. After a short stabilization period, the chambers were closed, and data were recorded using DatLab software 5.2 (Oroboros Instruments, Innsbruck, Austria).
To assess HUVEC mitochondrial respiratory function, we applied specifically designed substrate-uncoupler-inhibitor titrations in an extended experimental protocol. Routine respiration (no additives, Routine) was measured when the respiration was stabilized. Then, the plasma membrane was permeabilized with digitonin (Dig) (150 µg per 10 6 cells). The respiratory leak state of complex I (CI Leak ) was examined after titration with glutamate (G, 5 mM) and malate (M, 2 mM) in the absence of ADP. The oxidative phosphorylation capacity of complex I (CI OXPHOS ) was determined after adding 5 mM ADP. Succinate (100 mM) was added to induce maximal OXPHOS capacity via convergent input through both CI and complex II (CII, CI+II OXPHOS ). Subsequently, the maximal uncoupled respiratory capacity of the electron transfer system (ETS) was obtained by titrating FCCP (injected stepwise up to 1.5 µM) (CI+II ETS ). CII-supported uncoupled respiratory function (CII ETS ) was measured after adding rotenone (Rot, 0.5 µM). Residual oxygen consumption was evaluated after the addition of antimycin A (Ama, 2.5 µM).
Mitochondrial membrane potential
Mitochondrial membrane potential (MMP) was investigated using 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide (JC-1) (Beyotime, Shanghai, China) according to the manufacturer's instructions. Briefly, after the indicated treatments, cells cultured in six-well plates were stained with an equal amount of JC-1 staining solution for 20 minutes at 37℃ and washed twice with warm PBS. Then, the cells were placed in fresh serum-free medium, and MMP was determined using a fluorescence plate reader (Fluoroskan Ascent Fluorometer; Thermo, Helsinki, Finland) at 490 nm excitation and 530 nm emission for green fluorescence or at 525 nm excitation and 590 nm emission for red fluorescence. MMP was expressed as the ratio of the red/green fluorescence intensity.
Western blot analysis
Immunoblots for PKA, phosphorylated PKA (p-PKA), UCP2, eNOS, phosphorylated eNOS (p-eNOS), NADUFA9, and GAPDH were performed as previously described. 5 Primary antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). After incubation in secondary antibodies (ZSGB-BIO, China) at room temperature for 2 hours, the proteins were detected via enhanced 5 chemiluminescence and quantified using a Gel Doc 2000 Imager (Bio-Rad, USA). Protein expression was normalized to the expression of the internal control GAPDH.
Statistical analysis
The data were expressed as the means ± SEM. Concentration-response curves were analyzed by non-linear regression followed by Student's t-test for comparisons between two groups. One-way ANOVA and Student's t-test were used to examine the differences within or between groups (GraphPad Prism; La Jolla, CA, USA). Two-sided p-values less than 0.05 were considered statistically significant. Figure S10 Schematic Diagram of the protective effect of TRPV1-mediated UCP2 up-regulation in endothelial mitochondrial function ROS generation arises from several sources, including NADPH oxidase and the mitochondrial respiratory strain. ROS production increases eNOS uncoupling. Activation of TRPV1 increases PKA expression in endothelial cells. PKA inhibits NADPH activity, increases UCP2 expression and mitochondrial complex phosphorylation and further improves NO bioavailability.
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